Statement Of Cash Flows [Abstract]

ChemoMetec - Filing #1269875

Concept	2023-07-01 to 2024-06-30	As at 2024-06-30	As at 2023-07-01	As at 2023-06-30	2022-07-01 to 2023-06-30	As at 2022-07-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	183,000 DKK	—	—	—	1,093 DKK	—
Interest received, classified as operating activities	8,075 DKK	—	—	—	2,457 DKK	—
Income taxes paid (refund), classified as operating activities	51,955 DKK	—	—	—	57,749 DKK	—
Cash flows from (used in) operating activities	129,002 DKK	—	—	—	154,146 DKK	—
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities	- DKK	—	—	—	- DKK	—
Purchase of property, plant and equipment, classified as investing activities	20,947 DKK	—	—	—	21,181 DKK	—
Purchase of intangible assets, classified as investing activities	22,584 DKK	—	—	—	19,635 DKK	—
Cash flows from (used in) investing activities	43,494 DKK	—	—	—	40,831 DKK	—
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities	320,000 DKK	—	—	—	14,000 DKK	—
Payments of lease liabilities, classified as financing activities	1,620 DKK	—	—	—	2,844 DKK	—
Dividends paid, classified as financing activities	104,415 DKK	—	—	—	- DKK	—
Other inflows (outflows) of cash, classified as financing activities	- DKK	—	—	—	67,000 DKK	—
Cash flows from (used in) financing activities	105,715 DKK	—	—	—	2,925 DKK	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	20,207 DKK	—	—	—	110,390 DKK	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	218,000 DKK	—	—	—	2,844 DKK	—
Cash and cash equivalents	—	296,146 DKK	316,571 DKK	316,571 DKK	—	209,025 DKK